Machadka caafimaadka dadwaynaha Norway ayaa hadda ka fikiraya isticmaalka tallaalka borotiinka ee Nuvaxovid ee Norway.
- Tallaalku wuxuu ku habboonaan karaa tallaalka aasaasiga ah ee dadka waaweyn ee aan weli la tallaalin. Ama sida qiyaas dib-u-cusboonaysiin ah oo loogu talagalay dadka horay looga tallaalay tallaallada kale ee COVID-19 ee aan ku isticmaalnay Norway. Ayay tidhi madaxa caafimaadka Sara Viksmoen Watle oo ku sugan qaybta xakamaynta iyo talaalka caabuqa ee FHI.
Nuvaxovid by Novavax wali lagama heli karo Norway, laakiin waxaa ansixiyay Wakaaladda Daawooyinka Yurub (EMA) ka hor Christmas-ka. Sida laga soo xigtay wakaaladda dawooyinka Norway, saameynteeda ka hortagga dhibaatooyinka halista ah iyo dhimashada waa 90 boqolkiiba.
Si ka duwan tallaallada kale, kani waa tallaal borotiin ku salaysan.
Saynis yahanadu waxay rajeynayaan in tallaalada noocan ahi ay awood u yeelan doonaan inay bixiyaan ilaalin ka hortag ah oo muddo dheer ah, sidaa darteed dad badan ayaa qaadan doona.
Xigasho: NTB
(Sawirka AP/Charles Krupa)
Akhri maqaalkeena xiga: Sida loo hubiyo shahaadadaada coronavirus ee Norway